General Principles of Preclinical Study Design
Citations Over TimeTop 1% of 2019 papers
Abstract
Preclinical studies using animals to study the potential of a therapeutic drug or strategy are important steps before translation to clinical trials. However, evidence has shown that poor quality in the design and conduct of these studies has not only impeded clinical translation but also led to significant waste of valuable research resources. It is clear that experimental biases are related to the poor quality seen with preclinical studies. In this chapter, we will focus on hypothesis testing type of preclinical studies and explain general concepts and principles in relation to the design of in vivo experiments, provide definitions of experimental biases and how to avoid them, and discuss major sources contributing to experimental biases and how to mitigate these sources. We will also explore the differences between confirmatory and exploratory studies, and discuss available guidelines on preclinical studies and how to use them. This chapter, together with relevant information in other chapters in the handbook, provides a powerful tool to enhance scientific rigour for preclinical studies without restricting creativity.
Related Papers
- → Methodological rigour in preclinical urology: a systematic review reporting research quality over a 14‐year period(2023)2 cited
- Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design.(1990)
- → Methodological Rigour in Preclinical Urological Studies: a 14-year systematic review to increase research quality and value(2022)
- → Evaluating Study Design Rigor in Preclinical Cardiovascular Research: A Replication Study(2023)
- → Reviewer #1 (Public Review): Evaluating Study Design Rigor in Preclinical Cardiovascular Research: A Replication Study(2023)